 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval) F6 \9 F: @3 x, z5 o4 s; s, G
& u, V6 z& P5 V8 p
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
' f& B# y E" H, P
7 Z, s ~$ m' ^/ G4 yBY THE EDMONTON JOURNAL FEBRUARY 16, 20078 C4 C9 G& p. I0 w- r: ]: X
' X- B0 w* `0 I: y1 O9 U$ f & k* ^, A: V$ T4 k4 _3 ?
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.' U$ D! u. B0 l8 ~) z& M* S
. `3 i. o4 ]; `& |8 q8 F- ]" p5 Q
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
3 j p6 g2 B( L( r0 g8 R1 T3 M9 V8 y
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
) g: W4 K! I: N9 X* N4 r5 g5 D/ L/ t" v, z, e! e! C
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
" p8 `: n I9 T" z/ D
# H" i. P5 P& v2 H. \) XIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
* `. O' S C" y( }4 c
" ^) c' B! H! H0 Q"As a scientist, it's one of the highlights of my CAREER," Shan said./ y2 a L- i6 T# y
$ K/ `: Z5 K0 S( b2 u
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."3 Y; }$ C& A) f' E$ L
+ v6 {9 j* ^ L9 K0 m4 H6 U
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
; ]5 V" B7 X% {7 o. z {
5 z5 J4 c: d, r: Z. T1 T: DGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
+ P8 i+ I" h: ~9 e9 f
8 ~& s) q0 e3 NThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.) C, w1 R: j; G; o
, S' W5 w9 g7 X0 C5 D) e5 E9 p; t' ^& W0 _0 r [% O$ [
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|